aspirin-9781455707232
-
Upload
subbie-outlier -
Category
Documents
-
view
216 -
download
0
Transcript of aspirin-9781455707232
8122019 aspirin-9781455707232
httpslidepdfcomreaderfullaspirin-9781455707232 13
herb underlined ndash top prescribed drug
aspirinHIGHALERT
(acetylsalicylicacid ASA)
as-pir-in(Asaphen EC Ascriptin BayerBufferin Ecotrin Entrophen Halfprin Novasen ZORprin)Do not confuse aspirin or As-criptin with Afrin Aricept or
Asendin Ecotrin with Epogen
or ZORprin with ZyloprimFIXED-COMBINATION(S)
Aggrenox aspirindipyridamole(an antiplatelet agent) 25 mg200mg Fiorinal aspirinbutalbitalcaf-feine (a barbiturate) 325 mg50mg40 mg LortabASA aspirinhy-drocodone (an analgesic) 325 mg5mg Percodan aspirinoxycodone(an analgesic) 325 mg225 mg325 mg45 mg Pravigard aspirin pravastatin (a cholesterol-loweringagent) 81 mg20 mg 81 mg40 mg81 mg80 mg 325 mg20 mg 325
mg40 mg 325 mg80 mg
983157 CLASSIFICATION
PHARMACOTHERAPEUTIC Nonste-roidal salicylate CLINICAL Anti-inflammatory antipyretic anticoagu-lant (see pp 32C 127C)
ACTION
Inhibits prostaglandin synthesis acts on thehypothalamus heat-regulating center inter-feres with production of thromboxane A asubstance that stimulates platelet aggrega-
tion Therapeutic Effect Reduces inflam-matory response intensity of pain de-creases fever inhibits platelet aggregation
PHARMACOKINETICS
Route Onset Peak Duration
PO 1 hr 2ndash4 hrs 4ndash6 hrs
Rapidly and completely absorbed fromGI tract enteric-coated absorption de-layed rectal absorption delayed and in-complete Protein binding High Widelydistributed Rapidly hydrolyzed to salicy-late Half-life 15ndash20 min (aspirin)
2ndash3 hrs (salicylate at low dose) morethan 20 hrs (salicylate at high dose)
USES
Treatment of mild to moderate pain feverReduces inflammation related to rheuma-toid arthritis (RA) juvenile arthritis os-
teoarthritis rheumatic fever As plateletaggregation inhibitor in the prevention oftransient ischemic attacks (TIAs) cere-bral thromboembolism MI or reinfarc-tion Adjunctive treatment of Kawasakirsquosdisease OFF-LABEL Prevention of pre-eclampsia alternative therapy for prevent-ing thromboembolism associated withatrial fibrillation where warfarin cannot beused pericarditis associated with MIprosthetic valve thromboprophylaxis
PRECAUTIONS
Contraindications Hypersensitivity to sa-licylates NSAIDs asthma rhinitis nasal
polyps inherited or acquired bleedingdisorders use in children for viral infec-tions pregnancy Cautions Platelet bleeding disorders severe renalhepaticimpairment dehydration erosive gastri-tis peptic ulcer disease sensitivity totartrazine dyes
LIFESPAN CONSIDERATIONS
PregnancyLactation Readily crossesplacenta distributed in breast milk Mayprolong gestation and labor decreasefetal birth weight increase incidence ofstillbirths neonatal mortality hemor-
rhage Avoid use during last trimester(may adversely affect fetal cardiovascu-lar system premature closure of ductusarteriosus) Pregnancy Category C (D iffull dose used in third trimester of
pregnancy) Children Caution in those with acute febrile illness (Reyersquos syn-drome) Elderly May be more suscep-
8122019 aspirin-9781455707232
httpslidepdfcomreaderfullaspirin-9781455707232 23
Canadian trade name Non-Crushable Drug High Alert drug
tible to toxicity lower dosages recom-mended
INTERACTIONS
DRUG Alcohol NSAIDs may increaserisk of GI effects (eg ulceration) Ant-
acids urinary alkalinizers increaseexcretion Anticoagulants heparin
thrombolytics increase risk of bleed-ing Platelet aggregation inhibitors
valproic acid may increase risk ofbleeding May increase toxicity of meth-otrexate zidovudine Ototoxic med-
ications vancomycin may increaseototoxicity May decrease effect of pro-benecid sulfinpyrazone HERBAL
Avoid catrsquos claw dong quai evening primrose feverfew garlic gingerginkgo ginseng green tea horsechestnut red clover (possess anti-platelet activity) FOOD None knownLAB VALUES May alter serum AST ALTalkaline phosphatase uric acid prolongsprothrombin time (PT) bleeding timeMay decrease serum cholesterol potas-sium T3 T4
AVAILABILITY (OTC)
Caplets (Bayer) 81 mg 325 mg 500 mgSuppositories 300 mg 600 mg Tablets 162 mg (Halfprin) 325 mg (Bayer) 500mg (Bayer) Tablets (Chewable [Bayer St
Joseph]) 81 mg
Tablets (Enteric-Coated [Bayer Eco-
trin St Joseph]) 81 mg 325 mg 500
mg 650 mg
ADMINISTRATIONHANDLING
PO
bull Do not crush or break enteric-coatedtablets bull May give with water milk
meals if GI distress occurs
Rectal
bull Refrigerate suppositories do notfreeze bull If suppository is too soft chillfor 30 min in refrigerator or run cold
water over foil wrapper bull Moisten sup-pository with cold water before inserting
well into rectum
INDICATIONSROUTESDOSAGE
Analgesia Fever
PO RECTAL ADULTS ELDERLY 325ndash650mg q4ndash6h CHILDREN 10ndash15 mgkgdoseq4ndash6h Maximum 4 gday
Anti-InflammatoryPO ADULTS ELDERLY Initially 24ndash36 gday in divided doses then 36ndash54gday CHILDREN Initially 60ndash90 mgkg day in divided doses then 80ndash100 mg kgday
Platelet Aggregation InhibitorPO ADULTS ELDERLY 80ndash325 mgday
Kawasakirsquos Disease
PO CHILDREN 80ndash100 mgkgday in di- vided doses q6h After fever resolves3ndash5 mgkg once a day
SIDE EFFECTSOccasional GI distress (including ab-dominal distention cramping heart-burn mild nausea) allergic reaction(including bronchospasm pruritus urti-caria)
ADVERSE EFFECTS TOXIC REACTIONS
High doses of aspirin may produce GIbleeding andor gastric mucosal lesionsDehydrated febrile children may ex-perience aspirin toxicity quickly Reyersquossyndrome may occur in children with
chickenpox or flu Low-grade toxicitycharacterized by tinnitus generalizedpruritus (may be severe) headache diz-ziness flushing tachycardia hyperventi-lation diaphoresis thirst Marked toxic-ity characterized by hyperthermiarestlessness seizures abnormal breath-
ing patterns respiratory failure coma
NURSING CONSIDERATIONS
BASELINE ASSESSMENT
Do not give to children or teenagers whohave flu or chickenpox (increases risk ofReyersquos syndrome) Do not use if vinegar-like odor is noted (indicates chemical
8122019 aspirin-9781455707232
httpslidepdfcomreaderfullaspirin-9781455707232 33
breakdown) Assess type location dura-tion of pain inflammation Inspect ap-pearance of affected joints for immobilitydeformities skin condition Therapeuticserum level for antiarthritic effect 20ndash30 mgdl (toxicity occurs if level is
greater than 30 mgdl)INTERVENTIONEVALUATION
Monitor urinary pH (sudden acidification
pH from 65 to 55 may result in toxicity) Assess skin for evidence of ecchymosis Ifgiven as antipyretic assess temperaturedirectly before and 1 hr after giving medi-
cation Evaluate for therapeutic responserelief of pain stiffness swelling increasedjoint mobility reduced joint tendernessimproved grip strength
PATIENTFAMILY TEACHING
bull Do not crush or chew enteric-coated
tablets bull Avoid alcohol bull Report tinnitusor persistent abdominal GI pain bleedingbull Therapeutic anti-inflammatory effectnoted in 1ndash3 wks bull Behavioral changes
vomiting may be early signs of Reyersquos syn-drome Contact physician
8122019 aspirin-9781455707232
httpslidepdfcomreaderfullaspirin-9781455707232 23
Canadian trade name Non-Crushable Drug High Alert drug
tible to toxicity lower dosages recom-mended
INTERACTIONS
DRUG Alcohol NSAIDs may increaserisk of GI effects (eg ulceration) Ant-
acids urinary alkalinizers increaseexcretion Anticoagulants heparin
thrombolytics increase risk of bleed-ing Platelet aggregation inhibitors
valproic acid may increase risk ofbleeding May increase toxicity of meth-otrexate zidovudine Ototoxic med-
ications vancomycin may increaseototoxicity May decrease effect of pro-benecid sulfinpyrazone HERBAL
Avoid catrsquos claw dong quai evening primrose feverfew garlic gingerginkgo ginseng green tea horsechestnut red clover (possess anti-platelet activity) FOOD None knownLAB VALUES May alter serum AST ALTalkaline phosphatase uric acid prolongsprothrombin time (PT) bleeding timeMay decrease serum cholesterol potas-sium T3 T4
AVAILABILITY (OTC)
Caplets (Bayer) 81 mg 325 mg 500 mgSuppositories 300 mg 600 mg Tablets 162 mg (Halfprin) 325 mg (Bayer) 500mg (Bayer) Tablets (Chewable [Bayer St
Joseph]) 81 mg
Tablets (Enteric-Coated [Bayer Eco-
trin St Joseph]) 81 mg 325 mg 500
mg 650 mg
ADMINISTRATIONHANDLING
PO
bull Do not crush or break enteric-coatedtablets bull May give with water milk
meals if GI distress occurs
Rectal
bull Refrigerate suppositories do notfreeze bull If suppository is too soft chillfor 30 min in refrigerator or run cold
water over foil wrapper bull Moisten sup-pository with cold water before inserting
well into rectum
INDICATIONSROUTESDOSAGE
Analgesia Fever
PO RECTAL ADULTS ELDERLY 325ndash650mg q4ndash6h CHILDREN 10ndash15 mgkgdoseq4ndash6h Maximum 4 gday
Anti-InflammatoryPO ADULTS ELDERLY Initially 24ndash36 gday in divided doses then 36ndash54gday CHILDREN Initially 60ndash90 mgkg day in divided doses then 80ndash100 mg kgday
Platelet Aggregation InhibitorPO ADULTS ELDERLY 80ndash325 mgday
Kawasakirsquos Disease
PO CHILDREN 80ndash100 mgkgday in di- vided doses q6h After fever resolves3ndash5 mgkg once a day
SIDE EFFECTSOccasional GI distress (including ab-dominal distention cramping heart-burn mild nausea) allergic reaction(including bronchospasm pruritus urti-caria)
ADVERSE EFFECTS TOXIC REACTIONS
High doses of aspirin may produce GIbleeding andor gastric mucosal lesionsDehydrated febrile children may ex-perience aspirin toxicity quickly Reyersquossyndrome may occur in children with
chickenpox or flu Low-grade toxicitycharacterized by tinnitus generalizedpruritus (may be severe) headache diz-ziness flushing tachycardia hyperventi-lation diaphoresis thirst Marked toxic-ity characterized by hyperthermiarestlessness seizures abnormal breath-
ing patterns respiratory failure coma
NURSING CONSIDERATIONS
BASELINE ASSESSMENT
Do not give to children or teenagers whohave flu or chickenpox (increases risk ofReyersquos syndrome) Do not use if vinegar-like odor is noted (indicates chemical
8122019 aspirin-9781455707232
httpslidepdfcomreaderfullaspirin-9781455707232 33
breakdown) Assess type location dura-tion of pain inflammation Inspect ap-pearance of affected joints for immobilitydeformities skin condition Therapeuticserum level for antiarthritic effect 20ndash30 mgdl (toxicity occurs if level is
greater than 30 mgdl)INTERVENTIONEVALUATION
Monitor urinary pH (sudden acidification
pH from 65 to 55 may result in toxicity) Assess skin for evidence of ecchymosis Ifgiven as antipyretic assess temperaturedirectly before and 1 hr after giving medi-
cation Evaluate for therapeutic responserelief of pain stiffness swelling increasedjoint mobility reduced joint tendernessimproved grip strength
PATIENTFAMILY TEACHING
bull Do not crush or chew enteric-coated
tablets bull Avoid alcohol bull Report tinnitusor persistent abdominal GI pain bleedingbull Therapeutic anti-inflammatory effectnoted in 1ndash3 wks bull Behavioral changes
vomiting may be early signs of Reyersquos syn-drome Contact physician
8122019 aspirin-9781455707232
httpslidepdfcomreaderfullaspirin-9781455707232 33
breakdown) Assess type location dura-tion of pain inflammation Inspect ap-pearance of affected joints for immobilitydeformities skin condition Therapeuticserum level for antiarthritic effect 20ndash30 mgdl (toxicity occurs if level is
greater than 30 mgdl)INTERVENTIONEVALUATION
Monitor urinary pH (sudden acidification
pH from 65 to 55 may result in toxicity) Assess skin for evidence of ecchymosis Ifgiven as antipyretic assess temperaturedirectly before and 1 hr after giving medi-
cation Evaluate for therapeutic responserelief of pain stiffness swelling increasedjoint mobility reduced joint tendernessimproved grip strength
PATIENTFAMILY TEACHING
bull Do not crush or chew enteric-coated
tablets bull Avoid alcohol bull Report tinnitusor persistent abdominal GI pain bleedingbull Therapeutic anti-inflammatory effectnoted in 1ndash3 wks bull Behavioral changes
vomiting may be early signs of Reyersquos syn-drome Contact physician